Description of Business and Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties

The Company’s net revenue and cost of revenue and goods sold as shown on the condensed consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):

	Three Months Ended March 31,
	2023		2022
Net revenue:
Product sales (1)	$	28,726	$	10,520
Services (2)		222		1,472
Royalties (3)		11,678		—
Total net revenue	$	40,626	$	11,992

_________________________

(1)Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.

(2)Amounts represent revenue generated from the Company's collaboration arrangements, including Next-Gen R&D Services (as defined in Note 10) for UT as well as arrangements with other collaboration partners. See Note 10 – Collaboration, Licensing and Other Arrangements.

(3)Amounts represent royalties on UT’s net sales of Tyvaso DPI.

	Three Months Ended March 31,
	2023		2022
Cost of goods sold and cost of revenue:
Product sales	$	16,028	$	9,650
Services		185		1,348
Total cost of goods sold and cost of revenue	$	16,213	$	10,998